CRISPR-Cas Gene Editing to Cure Serious Diseases: Treat the Patient, Not the Germ Line.
The American journal of bioethics : AJOB, 15(12): 38-40 PMID 26632360 DOI 10.1080/15265161.2015.1103817
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.